New Key Statistics Module, Z-Score and F-Score
NAS:PRTK Key Ratios
| Market Cap $ M | 127.83 |
| Enterprise Value $ M | 344.90 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 111.11 |
| Price/Book | -- |
| Price/Sales | 0.71 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 167.00 |
| EPS (TTM) $ | -1.10 |
| Beneish M-Score | -3.21 |
| 10-y EBITDA Growth Rate % | 21.30 |
| 5-y EBITDA Growth Rate % | 26.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.71 |
| EV-to-EBITDA | -7.77 |
| PEG | -- |
| Shares Outstanding M | 57.32 |
| Net Margin (%) | -37.77 |
| Operating Margin % | -26.89 |
| Pre-tax Margin (%) | -37.67 |
| Quick Ratio | 0.46 |
| Current Ratio | 0.52 |
| ROA % (ttm) | -39.95 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -41.37 |
| Dividend Yield % | -- |
| Altman Z-Score | -9.69 |
PRTK Number of Guru Trades
PRTK Volume of Guru Trades
Gurus Latest Trades with NAS:PRTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRTK is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Paratek Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:PRTK
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers